NCT00598975 2021-07-12
NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)
Nektar Therapeutics
Phase 2 Completed
Nektar Therapeutics
Nektar Therapeutics